News

Dr Emma Pepperell, CEO, bit.bio speaks with Silicon Republic about how bit.bio’s programmed human cells are advancing research and...

bit.bio Chairman Lord David Prior speaks with EMJ at the Human Cell Forum about the future of the NHS, cell therapies, and human-c...

bit.bio launches new media kits for human iPSC-derived ioCells designed to make human cell-based research significantly more acces...

bit.bio CEO Emma Pepperell joins TechRound to discuss why reliable healthcare must start with consistent, reproducible science in ...

New human iPSC-derived hepatocyte model engineered for predictive reproducibility, chronic toxicity studies, and enhanced clinical...

bit.bio appoints Dr Emma Pepperell as Chief Executive Officer

bit.bio outlines a transformative vision for drug discovery at The Human Cell Forum, emphasising the need for human cell-based mod...

bit.bio lowers ioCells pricing and opens EU hub with next-day delivery, expanding global access to human cells for NAMs research.